Compass Therapeutics (CMPX) Free Cash Flow Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 137.65% |
| 10 | Compass Therapeutics | 418.47 Mn | 223.78 Mn | - | -31.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.19% |
| Dec 31, 2025 | -44.66% |
| Sep 30, 2025 | 2.15% |
| Jun 30, 2025 | -10.02% |
| Mar 31, 2025 | 4.77% |
| Dec 31, 2024 | 25.89% |
| Sep 30, 2024 | -87.04% |
| Jun 30, 2024 | -6.22% |
| Mar 31, 2024 | -13.57% |
| Dec 31, 2023 | -15.60% |
| Sep 30, 2023 | 45.92% |
| Jun 30, 2023 | -123.14% |
| Mar 31, 2023 | -50.31% |
| Dec 31, 2022 | -96.53% |
| Sep 30, 2022 | -186.85% |
| Jun 30, 2022 | 26.85% |
| Mar 31, 2022 | -41.10% |
| Sep 30, 2021 | 81.12% |
| Jun 20, 2021 | 52.57% |
| Mar 31, 2021 | 25.82% |
| Sep 30, 2020 | 23.37% |
| Jun 30, 2020 | 33.62% |
| Dec 31, 2019 | -140.64% |
| Jun 30, 2019 | -249,456.63% |